title: Cytokine and nitric oxide production in the acute phase of bacterial cell wall-induced arthritis.
abstract: We have investigated the temporal relationship among proinflammatory cytokine expression, nitric oxide (NO) production and joint inflammation in the acute phase of bacterial cell wall-derived peptidoglycan polysaccharide (PG/PS)-induced arthritis. Acute joint inflammation was induced in female LEW/N rats by a single intraperitoneal injection of PG/PS. Arthritis index and paw volume were quantified and joint histopathology was evaluated during acute joint inflammation (0-10 days). Tumor necrosis factor (TNF), interleukin-1 (IL-1) and interleukin-6 (IL-6) were determined by bioassay whereas nitric oxide (NO) was quantified by measuring serum nitrate/nitrite levels via the Griess procedure. We found that serum levels of TNF and serum IL-1 preceded the increase in IL-6 and NO production. Furthermore, the production of these proinflammatory cytokines and NO preceded bone erosion and osteoclast activity. Erosion of subchondral bone preceded pannus formation and cellular synovitis in the acute phase of PG/PS-induced arthritis. The temporal expression of TNF, IL-1, IL-6 and NO suggest a cascade of inflammatory mediators in which monocytes and macrophages respond to PG/PS with enhanced synthesis of TNF and IL-1, which may in turn promote the synthesis of IL-6 and NO. We postulate that one or more of these inflammatory events are responsible for initiating the subchondral bone erosion observed in acute joint inflammation.
authors.affiliation: Louisiana State University Medical Center, Department of Medicine, Shreveport 71130, USA.
authors.forename: J W
authors.initials: JW
authors.lastname: Fuseler
authors.forename: E M
authors.initials: EM
authors.lastname: Conner
authors.forename: J M
authors.initials: JM
authors.lastname: Davis
authors.forename: R E
authors.initials: RE
authors.lastname: Wolf
authors.forename: M B
authors.initials: MB
authors.lastname: Grisham
mesh_terms: D000208:Acute Disease; D000818:Animals; D001168:Arthritis / Q000209:etiology / Q000276:immunology* / Q000378:metabolism*; D016207:Cytokines / Q000096:biosynthesis*; D005260:Female; D007274:Injections, Intraperitoneal; D007375:Interleukin-1 / Q000096:biosynthesis; D015850:Interleukin-6 / Q000096:biosynthesis; D009569:Nitric Oxide / Q000096:biosynthesis*; D010457:Peptidoglycan / Q000008:administration & dosage / Q000633:toxicity*; D051381:Rats; D011917:Rats, Inbred Lew; D013290:Streptococcal Infections / Q000209:etiology / Q000276:immunology / Q000378:metabolism; D013297:Streptococcus pyogenes / Q000737:chemistry; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
chemical_list: D016207:Cytokines; D007375:Interleukin-1; D015850:Interleukin-6; D010457:Peptidoglycan; D014409:Tumor Necrosis Factor-alpha; D009569:Nitric Oxide